Full name
SPECJALISTYCZNY SZPITAL ONKOLOGICZNY NU-MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.10.Z - Hospital activities
47.74.Z - Retail sale of medical and orthopedic products
64.92.Z - Other forms of credit granting
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
85.60.Z - Educational support activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.C - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -5,8 | 4,9 | 9,1 | 85,4 |
EBITDA | -5 | 6,2 | 10,6 | 70,1 |
Short time liabilities | 63,2 | 55,7 | 18,3 | -67,2 |
Equity capital | -15,7 | -11,2 | -4,1 | 63,5 |
Operating profit (EBIT) | 0,4 | 11,2 | 15,7 | 39,7 |
Assets | 54,8 | 49,8 | 48,5 | -2,6 |
Net profit (loss) | -5,2 | 4,5 | 7,1 | 58,8 |
Cash | 5,9 | 2,8 | 0,3 | -90,5 |
Liabilities and provisions for liabilities | 70,5 | 61 | 52,6 | -13,8 |
Net income from sale | 89,1 | 105,8 | 128,9 | 21,8 |
Working assets | 18,6 | 18,3 | 20,3 | 11 |
Depreciation | -5,3 | -5 | -5,2 | -2,4 |
% | % | % | p.p. | |
Profitability of capital | 32,8 | -40 | -173,9 | -133,9 |
Equity capital to total assets | -28,6 | -22,5 | -8,4 | 14,1 |
Gross profit margin | -6,5 | 4,6 | 7 | 2,4 |
EBITDA Margin | -5,6 | 5,9 | 8,2 | 2,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 259 | 192 | 52 | -140 |
Current financial liquidity indicator | 0.2784080505371094 | 0.30865323543548584 | 0.9518988728523254 | 0,7 |
Net dept to EBITDA | -7.5269389152526855 | 5.431369304656982 | 3.129631280899048 | -2,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane